201 related articles for article (PubMed ID: 21106952)
21. Hydrogen Sulfide Attenuates Tissue Plasminogen Activator-Induced Cerebral Hemorrhage Following Experimental Stroke.
Liu H; Wang Y; Xiao Y; Hua Z; Cheng J; Jia J
Transl Stroke Res; 2016 Jun; 7(3):209-19. PubMed ID: 27018013
[TBL] [Abstract][Full Text] [Related]
22. Granulocyte colony-stimulating factor attenuates delayed tPA-induced hemorrhagic transformation in ischemic stroke rats by enhancing angiogenesis and vasculogenesis.
dela Peña IC; Yoo A; Tajiri N; Acosta SA; Ji X; Kaneko Y; Borlongan CV
J Cereb Blood Flow Metab; 2015 Feb; 35(2):338-46. PubMed ID: 25425079
[TBL] [Abstract][Full Text] [Related]
23. Ebselen, a seleno-organic antioxidant, is neuroprotective after embolic strokes in rabbits: synergism with low-dose tissue plasminogen activator.
Lapchak PA; Zivin JA
Stroke; 2003 Aug; 34(8):2013-8. PubMed ID: 12855833
[TBL] [Abstract][Full Text] [Related]
24. Antiactin-targeted immunoliposomes ameliorate tissue plasminogen activator-induced hemorrhage after focal embolic stroke.
Asahi M; Rammohan R; Sumii T; Wang X; Pauw RJ; Weissig V; Torchilin VP; Lo EH
J Cereb Blood Flow Metab; 2003 Aug; 23(8):895-9. PubMed ID: 12902833
[TBL] [Abstract][Full Text] [Related]
25. Angioedema and Hemorrhage After 4.5-Hour tPA (Tissue-Type Plasminogen Activator) Thrombolysis Ameliorated by T541 via Restoring Brain Microvascular Integrity.
Chen QF; Liu YY; Pan CS; Fan JY; Yan L; Hu BH; Chang X; Li Q; Han JY
Stroke; 2018 Sep; 49(9):2211-2219. PubMed ID: 30354988
[TBL] [Abstract][Full Text] [Related]
26. Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke.
Castellanos M; Leira R; Serena J; Blanco M; Pedraza S; Castillo J; Dávalos A
Stroke; 2004 Jul; 35(7):1671-6. PubMed ID: 15166391
[TBL] [Abstract][Full Text] [Related]
27. High-density lipoprotein-based therapy reduces the hemorrhagic complications associated with tissue plasminogen activator treatment in experimental stroke.
Lapergue B; Dang BQ; Desilles JP; Ortiz-Munoz G; Delbosc S; Loyau S; Louedec L; Couraud PO; Mazighi M; Michel JB; Meilhac O; Amarenco P
Stroke; 2013 Mar; 44(3):699-707. PubMed ID: 23422087
[TBL] [Abstract][Full Text] [Related]
28. Early administration of pyrrolidine dithiocarbamate extends the therapeutic time window of tissue plasminogen activator in a male rat model of embolic stroke.
Wang Z; Shan W; Cao J; Wintermark M; Huang W; Zuo Z
J Neurosci Res; 2018 Mar; 96(3):449-458. PubMed ID: 28976017
[TBL] [Abstract][Full Text] [Related]
29. Fingolimod reduces hemorrhagic transformation associated with delayed tissue plasminogen activator treatment in a mouse thromboembolic model.
Campos F; Qin T; Castillo J; Seo JH; Arai K; Lo EH; Waeber C
Stroke; 2013 Feb; 44(2):505-11. PubMed ID: 23287783
[TBL] [Abstract][Full Text] [Related]
30. Effects of ML351 and tissue plasminogen activator combination therapy in a rat model of focal embolic stroke.
Cheng G; Zhao W; Xin Y; Huang G; Liu Y; Li Z; Zhan M; Li Y; Lu L; van Leyen K; Liu Y
J Neurochem; 2021 May; 157(3):586-598. PubMed ID: 33481248
[TBL] [Abstract][Full Text] [Related]
31. 17β-estradiol attenuates breakdown of blood-brain barrier and hemorrhagic transformation induced by tissue plasminogen activator in cerebral ischemia.
Li M; Zhang Z; Sun W; Koehler RC; Huang J
Neurobiol Dis; 2011 Dec; 44(3):277-83. PubMed ID: 21816222
[TBL] [Abstract][Full Text] [Related]
32. tPA Mobilizes Immune Cells That Exacerbate Hemorrhagic Transformation in Stroke.
Shi K; Zou M; Jia DM; Shi S; Yang X; Liu Q; Dong JF; Sheth KN; Wang X; Shi FD
Circ Res; 2021 Jan; 128(1):62-75. PubMed ID: 33070717
[TBL] [Abstract][Full Text] [Related]
33. Low dose tPA plus annexin A2 combination attenuates tPA delayed treatment-associated hemorrhage and improves recovery in rat embolic focal stroke.
Jiang Y; Fan X; Yu Z; Cheng C; Wang XS; Lo EH; Sun X; Wang X
Neurosci Lett; 2015 Aug; 602():73-8. PubMed ID: 26149229
[TBL] [Abstract][Full Text] [Related]
34. Postischemic intracarotid treatment with TNK-tPA reduces infarct volume and improves neurological deficits in embolic stroke in the unanesthetized rat.
Zhang RL; Zhang L; Jiang Q; Zhang ZG; Goussev A; Chopp M
Brain Res; 2000 Sep; 878(1-2):64-71. PubMed ID: 10996136
[TBL] [Abstract][Full Text] [Related]
35. Plasma VAP-1/SSAO activity predicts intracranial hemorrhages and adverse neurological outcome after tissue plasminogen activator treatment in stroke.
Hernandez-Guillamon M; Garcia-Bonilla L; Solé M; Sosti V; Parés M; Campos M; Ortega-Aznar A; Domínguez C; Rubiera M; Ribó M; Quintana M; Molina CA; Alvarez-Sabín J; Rosell A; Unzeta M; Montaner J
Stroke; 2010 Jul; 41(7):1528-35. PubMed ID: 20538694
[TBL] [Abstract][Full Text] [Related]
36. Effects of tissue plasminogen activator on cerebral microvessels of rats during focal cerebral ischemia and reperfusion.
Yang DY; Pan HC; Chen CJ; Cheng FC; Wang YC
Neurol Res; 2007 Apr; 29(3):274-82. PubMed ID: 17509227
[TBL] [Abstract][Full Text] [Related]
37. Effects of tissue type plasminogen activator in embolic versus mechanical models of focal cerebral ischemia in rats.
Meng W; Wang X; Asahi M; Kano T; Asahi K; Ackerman RH; Lo EH
J Cereb Blood Flow Metab; 1999 Dec; 19(12):1316-21. PubMed ID: 10598935
[TBL] [Abstract][Full Text] [Related]
38. Comparison of quantitative estimation of intracerebral hemorrhage and infarct volumes after thromboembolism in an embolic stroke model.
Eriksen N; Rasmussen RS; Overgaard K; Johansen FF; Pakkenberg B
Int J Stroke; 2014 Aug; 9(6):802-10. PubMed ID: 22928632
[TBL] [Abstract][Full Text] [Related]
39. IMM-H004 prevents toxicity induced by delayed treatment of tPA in a rat model of focal cerebral ischemia involving PKA-and PI3K-dependent Akt activation.
Zuo W; Chen J; Zhang S; Tang J; Liu H; Zhang D; Chen N
Eur J Neurosci; 2014 Jun; 39(12):2107-18. PubMed ID: 24649933
[TBL] [Abstract][Full Text] [Related]
40. Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke.
Montaner J; Molina CA; Monasterio J; Abilleira S; Arenillas JF; Ribó M; Quintana M; Alvarez-Sabín J
Circulation; 2003 Feb; 107(4):598-603. PubMed ID: 12566373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
